Co-Authors
This is a "connection" page, showing publications co-authored by Wei Wang and Fankai Meng.
Connection Strength
0.111
-
Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients. Cell Mol Immunol. 2020 09; 17(9):992-994.
Score: 0.056
-
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial. J Allergy Clin Immunol. 2020 Jul; 146(1):137-146.e3.
Score: 0.055